Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors

The aim of the present study was to evaluate the toxicity and efficacy of the FOLFOX-4 regimen as adjuvant chemotherapy in patients with gastric cancer after radical surgery. Fifty-four patients (1 stage Ib, 6 stage II, 22 stage IIIa, 14 stage IIIb and 11 stage IV) received 8-12 cycles of FOLFOX-4 (...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: CARLOMAGNO, CHIARA, MATANO, ELIDE, BIANCO, ROBERTO, CIMMINIELLO, CAROLINA, PRUDENTE, ANTONELLA, PAGLIARULO, CLORINDO, CRISPO, ANNA, CANNELLA, LUCIA, DE STEFANO, ALFONSO, D’ARMIENTO, FRANCESCO PAOLO, DE PLACIDO, SABINO
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2010
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3445918/
https://ncbi.nlm.nih.gov/pubmed/22993584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm_00000096
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller